MORRISTOWN, N.J. — Actavis has launched its version of an epilepsy drug made by UCB. The generic drug maker said it received approval from the Food and Drug Administration for levetiracetam ...

Individuals with epilepsy and their caregivers want improved communication and a broader base of information from their ...

BRUSSELS (Reuters) - Belgian pharma group UCB said on Monday that U.S. health authorities had approved epilepsy drug Keppra XR and that it would go on sale just before its mother drug loses patent ...

Artificial intelligence (AI) can help improve treatment of epilepsy by connecting the dots in complex cases, a new study says ...